These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3033846)
1. Dose-dependent elevation of Ah receptor binding by TCDD in rat liver. Sloop TC; Lucier GW Toxicol Appl Pharmacol; 1987 May; 88(3):329-37. PubMed ID: 3033846 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line. Harper PA; Golas CL; Okey AB Cancer Res; 1988 May; 48(9):2388-95. PubMed ID: 2833345 [TBL] [Abstract][Full Text] [Related]
3. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells. Harper PA; Golas CL; Okey AB Mol Pharmacol; 1991 Nov; 40(5):818-26. PubMed ID: 1658612 [TBL] [Abstract][Full Text] [Related]
4. Ah receptor mediating induction of cytochrome P450IA1 in a novel continuous human liver cell line (Mz-Hep-1). Detection by binding with [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin and relationship to the activity of aryl hydrocarbon hydroxylase. Roberts EA; Johnson KC; Dippold WG Biochem Pharmacol; 1991 Jul; 42(3):521-8. PubMed ID: 1650214 [TBL] [Abstract][Full Text] [Related]
5. Ah receptor mediating induction of aryl hydrocarbon hydroxylase: detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin. Roberts EA; Golas CL; Okey AB Cancer Res; 1986 Jul; 46(7):3739-43. PubMed ID: 3011254 [TBL] [Abstract][Full Text] [Related]
6. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Harris M; Zacharewski T; Astroff B; Safe S Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the Ah receptor mediating aryl hydrocarbon hydroxylase induction in the human liver cell line Hep G2. Roberts EA; Johnson KC; Harper PA; Okey AB Arch Biochem Biophys; 1990 Feb; 276(2):442-50. PubMed ID: 2154949 [TBL] [Abstract][Full Text] [Related]
8. The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Waithe WI; Michaud M; Harper PA; Okey AB; Anderson A Biochem Pharmacol; 1991 Jan; 41(1):85-92. PubMed ID: 1846074 [TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180. Harper PA; Prokipcak RD; Bush LE; Golas CL; Okey AB Arch Biochem Biophys; 1991 Oct; 290(1):27-36. PubMed ID: 1654865 [TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin binding to Ah receptor in a rainbow trout hepatoma cell line. Lorenzen A; Okey AB Toxicol Appl Pharmacol; 1990 Oct; 106(1):53-62. PubMed ID: 2174580 [TBL] [Abstract][Full Text] [Related]
11. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression. Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100 [TBL] [Abstract][Full Text] [Related]
12. Elevated binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice. Okey AB; Vella LM Biochem Pharmacol; 1984 Feb; 33(4):531-8. PubMed ID: 6322806 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6-[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes. Piskorska-Pliszczynska J; Astroff B; Zacharewski T; Harris M; Rosengren R; Morrison V; Safe L; Safe S Arch Biochem Biophys; 1991 Jan; 284(1):193-200. PubMed ID: 1846513 [TBL] [Abstract][Full Text] [Related]
14. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Leung HW; Paustenbach DJ; Murray FJ; Andersen ME Toxicol Appl Pharmacol; 1990 May; 103(3):399-410. PubMed ID: 2160135 [TBL] [Abstract][Full Text] [Related]
17. Induction of aryl hydrocarbon hydroxylase and demonstration of a specific nuclear receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in two human hepatoma cell lines. Labruzzo P; Yu XF; Dufresne MJ Biochem Pharmacol; 1989 Jul; 38(14):2339-48. PubMed ID: 2546564 [TBL] [Abstract][Full Text] [Related]
18. Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Species difference in molecular properties of the receptors from mouse and rat hepatic cytosols. Denison MS; Vella LM; Okey AB J Biol Chem; 1986 Mar; 261(9):3987-95. PubMed ID: 3005314 [TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Okey AB; Vella LM; Harper PA Mol Pharmacol; 1989 Jun; 35(6):823-30. PubMed ID: 2543914 [TBL] [Abstract][Full Text] [Related]
20. Effects of substituents on the cytosolic receptor-binding avidities and aryl hydrocarbon hydroxylase induction potencies of 7-substituted 2,3-dichlorodibenzo-p-dioxins. A quantitative structure-activity relationship analysis. Denomme MA; Homonoko K; Fujita T; Sawyer T; Safe S Mol Pharmacol; 1985 Jun; 27(6):656-61. PubMed ID: 2987660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]